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Abstract
Grouping variants based on gene mapping can augment the power of rare variant association tests. Weighting or
sorting variants based on their expected functional impact can provide additional benefit. We defined groups of
prioritized variants based on systematic annotation of Genetic Analysis Workshop 18 (GAW18) single-nucleotide
variants; we focused on variants detected by whole genome sequencing, specifically on the high-quality subset
presented in the genotype files. First, we divided variants between coding and noncoding. Coding variants are
fewer than 1% of the total and are more likely to have a biological effect than noncoding variants. Coding variants
were further stratified into protein changing and protein damaging groups based on the effect on protein amino
acid sequence. In particular, missense variants predicted to be damaging, splice-site alterations, and stop gains
were assigned to the protein damaging category. Impact of noncoding variants is more difficult to predict. We
decided to rely uniquely on conservation: we combined (a) the mammalian phastCons Conserved Element and (b)
the PhyloP score, which identify conserved intervals and the single-nucleotide position, respectively. This reduced
the noncoding variants to a number comparable to coding variants. Finally, using gene structure definition from
the widely used RefSeq database, we mapped variants to genes to support association tests that require collapsing
rare variants to genes. Companion GAW18 papers used these variant priority groups and gene mapping; one of
these paper specifically found evidence of stronger association signal for protein damaging variants.
Background
Next generation sequencing (NGS) technology, especially
the application of whole genome sequencing (WGS),
poses a major challenge in terms of the number of var-
iants to be analyzed [1,2]. Grouping variants based on
gene mapping can augment the power of rare variant
association tests [2]. In addition, association studies, as
well as other applications such as the search for Mende-
lian disease genes [1] or the interpretation of individual
genomes for personalized medicine [3], can benefit from
variant prioritization methods.
We prioritized Genetic Analysis Workshop 18
(GAW18) single-nucleotide variants based on criteria
previously described in the literature [1,2] and publicly
available bioinformatics resources.
First, we divided variants into coding and noncoding.
Coding variants are fewer than 1% of the total and are
more likely than noncoding variants to have a biological
effect because they can produce a change in the protein
sequence. Noncoding variants are more abundant and are
more difficult to assess for functional relevance; however,
many genome-wide association studies’ signals have been
found in noncoding regions, likely in correspondence of
regulatory sequences [4]. For this reason, we decided to
keep the two types of variants separate, and we decided to
comparatively evaluate the detection of association signals
for coding and noncoding variants. Both coding and non-
coding variants were stratified in two progressively more
stringent groups. For coding variants, the groups were
protein changing and protein damaging; for noncoding
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variants, the groups were medium conservation and high
conservation. Whereas coding variants were stratified
based on the type of change introduced in the protein
sequence, noncoding variants were stratified using evolu-
tionary conservation of genomic DNA sequence as a
proxy of functional relevance. Finally, variants were
mapped to genes based on the overlap with their tran-
script. Intergenic variants were mapped to the closest
gene, and ad-hoc rules were applied to minimize the num-
ber of variants mapping to multiple genes.
The Methods section describes in detail the tools and
rules used to generate primary annotation, sort variants
into priority groups, and map them to genes. The Results
section describes in detail the number of variants found
for each group and the rationale for the specific settings
used for priority group definitions; we also briefly sum-
marize results from a companion paper [5] showing the
presence of association signals for prioritized variants.
The Discussion section takes a critical look at the priori-
tization strategy adopted in this work in the context of
recent literature on variant prioritization, making a few
recommendations for future improvements.
Methods
Variant coordinates and alleles
GAW18 single-nucleotide variants were extracted from
genotype files (.geno.csv), corresponding to 464 sequenced
individuals; variants were provided for odd chromosomes.
We identified reference and alternate alleles by consider-
ing the nucleotide at corresponding positions in the
human genome reference sequence. Multi-allelic variants
were considered bi-allelic, by considering only the two
most frequent alleles; although not ideal, this substantially
simplifies the annotation pipeline. We used the human
genome reference sequence hg19 GRCh37.
Extraction of variant annotation from databases
Annovar [6] was used to (a) map variants to gene exons
and coding sequence on the basis of the RefSeq database
(based on hg19) and (b) classify variants as synonymous
(i.e., not expected to alter the protein sequence), missense
(i.e., amino acid changing), stop-loss, stop-gain, or
expected splicing alterations (defined as presence of alter-
nate alleles in the +/- 2-bp interval around intron/exon
boundaries). In the presence of overlapping genomic
regions (e.g., 3′ untranslated region (3′ UTR) of gene A
overlapping with coding exon of gene B), Annovar fol-
lows predefined annotation precedence (e.g., coding exon
has precedence over 3′ UTR); the precedence rules used
by Annovar are logically consistent with our variant
prioritization strategy, which assigns higher priority to
coding variants disrupting the protein sequence. Anno-
var’s gene mapping was parsed to minimize the number
of variants mapping to multiple genes: (a) we removed 68
read-through transcripts (i.e., transcripts that span two
genes), which may represent artifacts or have dubious
functional relevance, and (b) for intergenic regions, we
reported only the closest genes and we removed all genes
at a distance greater than 200 kbp.
To further classify missense variants, we used two
widely used predictors, SIFT [7] and Polyphen [8], and
combined their scores using CONDEL [9], a tool for
optimized consensus definition; in particular, SIFT
version 2.1.0 and Polyphen version 4.0.3 predictions
were generated for all possible variant positions. To
define noncoding variant conservation groups, we used
placental mammals phastConsElements [10] and PhyloP
[11] scores obtained from UCSC (based on hg19
coordinates).
Definition of variant priority groups
We categorized variants into two mutually exclusive
groups, coding and noncoding. For coding variants, we
defined three groups based on expected impact on protein
sequence: coding, protein changing, and protein damaging
groups. Correspondingly, for noncoding variants, we
defined three groups based on conservation: noncoding,
noncoding medium conservation, and noncoding high
conservation. The groups were defined as follows.
Variants categorized by Annovar as “splicing” or “exo-
nic” were assigned to the “coding” group; all other variants
(categorized by Annovar as “ncRNA”, “UTR3”, “UTR5”,
“intronic”, “upstream”, “downstream”, “intergenic”) were
assigned to the noncoding category. In addition, coding
variants categorized by Annovar as “splicing” or “exonic,
nonsynonymous”, “exonic, stop-gain” and “exonic, stop-
loss” were also assigned to the “protein changing” sub-
group of “coding”. Finally, “splicing”, “exonic, missense”
variants predicted “deleterious” by CONDEL (a subset of
“exonic, nonsynonymous” variants) and “exonic, stop-
gain” variants were assigned to the “protein damaging”
subgroup of “protein changing”.
Noncoding variants with mammalian phastCons Con-
served Element score greater than 0 and mammalian
PhyloP greater than 1 were assigned to the noncoding
subgroup “medium conservation”. The noncoding var-
iants satisfying more stringent cutoffs on conservation




We started from 8,348,674 high-quality single-nucleotide
variants defined in the GAW18 genotype files. We
decided to prioritize variants as groups rather than
using a continuous ranking for sake of simplicity
because several of the primary information items are
binary (e.g., exonic: yes/no, stop-gain: yes/no). Variants
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were first sorted into two mutually exclusive groups
(Figure 1), coding (74,363; 0.9%) and noncoding
(8,274,311; 99.1%).
Gene mappings
Gene mappings were parsed to remove mapping to read-
through genes, which represent transcripts spanning two
genes. Whereas some read-throughs are present in physio-
logical conditions, but their functional role is dubious,
other read-throughs are potential annotation artifacts.
Read-throughs introduce extra redundancy when collap-
sing variants to genes, which we deemed unnecessary.
After removing read-throughs, most of the coding variants
(99.74%) mapped only to one gene. Gene mappings of
intergenic variants were further processed by selecting
only the closest gene and removing genes at a distance
greater than 200 kbp; these rules could be regarded as
simplistic, yet they help minimizing overlaps when collap-
sing rare variants by gene. This resulted in 83.6% of all
noncoding variants mapping to one gene and only 0.34%
mapping to more than one gene.
Coding variant prioritization
Coding variants are a small minority, and they are more
likely than noncoding variants to have a biological effect
because they can produce a change in the protein
sequence. In addition, there is a (at least partial) consen-
sus on how to prioritize coding variants based on their
protein sequence impact. Coding variants were defined
as mapping to protein-coding exons as well as their
splice sites; UTRs are not part of protein-coding exons
and therefore were excluded. All other variants were
assigned to the noncoding group regardless of their type
(thus including UTRs and introns of protein-coding
genes, ncRNA genes, promoters, and intergenic regions).
Coding variants were labeled as protein changing
(40,667; 54.7% of coding variants) if they altered splicing
or if they changed at least one amino acid of the gene’s
protein sequence(s) (corresponding to the missense,
stop-gain, and stop-loss categories). Protein changing
variants were further labeled as protein damaging
(14,536; 19.5%) if they altered splicing, if they intro-
duced a stop codon, or if they produced an amino acid
change deemed damaging by CONDEL [9], a missense
variant impact consensus predictor that was used to
integrate SIFT [7] and Polyphen [8] predictions.
CONDEL weights predictions from these tools using a
data set of 20,000 missense variants, both deleterious
and neutral, and thus we deemed it superior to a simple
consensus rule.
Noncoding variant prioritization
To stratify noncoding variants, we used evolutionary
conservation. In fact, for variants mapping to annotated
noncoding RNAs or regulatory sequences (e.g., promo-
ters, methylation sites), there is no established consensus
Figure 1 Variant prioritization process and summary statistics. Arrows represent the identification progressively of smaller groups of
prioritized variants. Variant summary statistics are reported throughout the prioritization process; percentages in round brackets indicate the
number of variants retained at each prioritization step. Variant groups expected to produce better association results have a thicker border line.
Groups with a significant reduction in variant number are labeled in red.
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on how to predict the functional disruption. In addition,
many noncoding variants map to functionally relevant
regions that have not yet been annotated [1]. At least
some of the functionally relevant noncoding loci are
likely to be constrained evolutionarily, and this method
does depend on known annotations of functional ele-
ments. We defined two conservation priority groups
based on two widely used conservation scores, mamma-
lian phastCons Conserved Element [10] and PhyloP
[11]. PhastCons score is based on a hidden Markov
model that estimates the probability that each nucleo-
tide belongs to a conserved element based on multiple
alignment of genome sequences (placental mammal
sequences in our case); PhastCons is sensitive to runs of
conserved sites and is therefore effective at picking out
conserved elements. By contrast, PhyloP separately mea-
sures conservation at individual positions, ignoring the
conservation of neighboring positions. Variants with
phastCons greater than 0 and PhyloP greater than 1
were assigned to the medium conservation group
(74,317; 0.9% of all noncoding variants); variants with
phastCons greater than 400 and PhyloP greater than 1.5
were assigned to the high conservation group (28,948;
39.0% of medium conservation noncoding variants).
Well-characterized functional ncRNA elements (e.g.,
microRNAs) typically have phastCons greater than 400.
We also verified that 54.5% of the coding variants reside
within a phastCons greater than 0 genomic region, but
only 2.4% of noncoding variants satisfied the same
requirement (Figure 2), providing further support for
the selected phastCons thresholds. The PhyloP cutoff
was fine tuned to obtain a number of prioritized non-
coding variant comparable to coding variants.
Assessment of association for different priority groups
The GAW18 paper [5] assessed different gene-collapsed
rare variant association test for 103 unrelated individuals
with NGS data and real hypertension phenotype data,
only for chromosome 3. None of the genes was signifi-
cant after Bonferroni multiple test correction; however,
quantile-quantile plots, investigating the discrepancy
between real p-values and uniformly distributed p-values
expected under the null hypothesis of no association,
displayed an excess of nominally significant p-values for
the protein damaging group compared with all coding
variants. No signal was found for noncoding variants.
Discussion
We defined a simple yet robust variant prioritization
scheme using publicly available bioinformatics tools and
resources. We first divided variants into coding and
noncoding. Coding variants have a more straightforward
mapping to genes and are capable of directly altering
protein function. Nonetheless, at least some of the
Figure 2 Distribution of PhyloP and PhastCons scores. Histograms of PhyloP (A) and PhastCons (B) scores across Genetic Analysis Workshop
18 for high quality coding (light gray) and noncoding (dark gray) variants. Orange and pink dashed lines indicate cutoffs used for medium and
high conservation groups. For PhastCons, we also display a zoom over the distributions of score greater than 0.
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noncoding variants are expected to have a biologically
relevant effect on functional noncoding RNA or protein-
coding gene regulation. For both coding and noncoding
variants, we defined a more inclusive and more stringent
set of prioritized variants (coding: protein changing,
protein damaging; noncoding: medium conservation and
high conservation). We also provided gene mapping to
support the grouping of variants by gene for association
testing. These variant annotations were used in other
GAW18 proceeding papers [5,12]; one paper [5] specifi-
cally found the presence of stronger association signals
for protein damaging variants.
Several recent studies have investigated variants
expected to alter protein function. In the following section,
we summarize their findings and discuss their relevance
for variant prioritization in association studies.
A study taking advantage of the large NHLBI-ESP
exome variant database [13] has shown abundant rare
and deleterious genetic variants, many of which arose
recently in human evolutionary history because of accel-
erated population growth. Splice site alterations, stop-
gain, and missense predicted-damaging variants were all
shown to be on average more recent than synonymous
variants, and a similar pattern was found for noncoding
variants in conserved compared with nonconserved
positions. This validates our overall strategy.
A survey of common loss-of-function (LOF) variants
(including stop-gain and splice variants categorized as pro-
tein damaging in this study) [14] revealed several sources
of error to be reckoned: sequencing or mapping errors
(25.0%), annotation or reference sequence errors (26.8%),
and variants unlikely to be genuine LOF events because of
combined effects of other variants (11.1%). Excluding
sequencing errors, which have been minimized in the
GAW18 data set by additional quality filtering, these find-
ings suggest that a more sophisticated annotation pipeline
may be required to avoid false positive LOF variant anno-
tation. This includes time-consuming manual inspection
of all LOF variants, which was not practicable for this
study, as well as more nuanced filters, such as considering
the percentage of disrupted coding sequence and the
presence of variant combinations that could cancel out the
LOF in combination (only partially practicable in this
study because in/del variants were not available).
We are not aware of specific works setting community-
accepted standards for noncoding variants. Future work
in this field will be extremely relevant to variant
prioritization.
Conclusions
We defined a simple yet robust variant prioritization
scheme using publicly available bioinformatics tools and
resources. We also provided gene mapping to support
the grouping of variants by gene for association testing.
Association signal was specifically found for coding var-
iants predicted to be deleterious for protein function.
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